What is a common radiopharmaceutical used in PET imaging?

What is a common radiopharmaceutical used in PET imaging?

• A. Technetium-99m
• B. Fluorodeoxyglucose (FDG)
• C. Gallium-68
• D. Carbon-11

Answer: (B)

Fluorodeoxyglucose (FDG) is widely recognized as the most common radiopharmaceutical used in PET imaging. This compound is a glucose analog that is radiolabeled with fluorine-18, and it plays a crucial role in the detection and monitoring of various types of cancer. Cancer cells exhibit heightened metabolic activity and glucose uptake, which allows FDG to preferentially accumulate in malignant tissues. When a patient undergoes a PET scan with FDG, areas of increased radioactivity can be visualized, indicating potential tumors or areas of metastasis. This high sensitivity to metabolic changes makes FDG invaluable in oncology, including diagnosing, staging, and assessing treatment responses for tumors. Therefore, its significance in PET imaging lies in its ability to leverage the differences in glucose metabolism between healthy and diseased tissues, providing essential insights into the pathology being evaluated.

Fluorodeoxyglucose (FDG) is widely recognized as the most common radiopharmaceutical used in PET imaging. This compound is a glucose analog that is radiolabeled with fluorine-18, and it plays a crucial role in the detection and monitoring of various types of cancer. Cancer cells exhibit heightened metabolic activity and glucose uptake, which allows FDG to preferentially accumulate in malignant tissues.

When a patient undergoes a PET scan with FDG, areas of increased radioactivity can be visualized, indicating potential tumors or areas of metastasis. This high sensitivity to metabolic changes makes FDG invaluable in oncology, including diagnosing, staging, and assessing treatment responses for tumors. Therefore, its significance in PET imaging lies in its ability to leverage the differences in glucose metabolism between healthy and diseased tissues, providing essential insights into the pathology being evaluated.